BIO has fallen 5.51% in the past 24 hours, but there are some interesting technical aspects worth paying attention to.

First, let's look at the positive signals. The MACD has recently shown a bullish crossover, which typically indicates that upward momentum may be about to start. The RSI6 is currently at 54.87, suggesting that short-term buying pressure still exists, and a continued price increase is possible. There are also discussions in the community, believing that after liquidity sweeps, a bullish breakout pattern might form.

However, the actual fund flow is sending a different signal. In the past two hours, this asset experienced significant outflows of 153,551 USDT and 66,063 USDT, indicating considerable selling pressure in the market. From the moving averages, the 7-period EMA (0.04268) is still below the 25-period moving average (0.04294), suggesting that the short-term trend remains weak.

So, the current situation is somewhat conflicted—technical indicators hint at a possible rebound, but fund flow and price action are still exerting downward pressure. This mixed market sentiment requires continued monitoring; only once a clear breakout occurs can the strength of a reversal be confirmed.